| Cash and cash equivalents |
| 13. |
Cash
and cash equivalents |
Schedule
of cash and cash equivalents
| | |
| | |
| | |
June 30, | |
| | |
December 31, | | |
December 31, | | |
2025 | |
| | |
2025 | | |
2025 | | |
(Audited) | |
| | |
US$ | | |
S$ | | |
S$ | |
| | |
| | |
| | |
| |
| Cash on hand | |
| 460 | | |
| 591 | | |
| 395 | |
| Cash at banks | |
| 1,044,180 | | |
| 1,342,712 | | |
| 3,044,071 | |
| Cash
and cash equivalents | |
| 1,044,640 | | |
| 1,343,303 | | |
| 3,044,466 | |
Basel
Medical Group Ltd and its Subsidiaries
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
For
the financial period ended December 31, 2025
|
| 13. |
Cash and cash equivalents |
Schedule
of cash and cash equivalents
| | |
2025 | | |
2025 | | |
2024 | |
| | |
US$ | | |
S$ | | |
S$ | |
| | |
| | |
| | |
| |
| Cash on hand | |
| 311 | | |
| 395 | | |
| 1,500 | |
| Cash at banks | |
| 2,393,325 | | |
| 3,044,071 | | |
| 1,949,553 | |
| Cash
and cash equivalents | |
| 2,393,636 | | |
| 3,044,466 | | |
| 1,951,053 | |
|